- Taro Provides Results for Year Ended March 31, 2024
- Taro to Release Full Year Results on May 20, 2024
- Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger
- Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Key statistics
As of last trade Taro Pharmaceutical Industries Ltd (TARO:NYQ) traded at 42.67, -6.75% below its 52-week high of 45.76, set on Jan 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 42.76 |
---|---|
High | 42.76 |
Low | 42.65 |
Bid | 42.66 |
Offer | 42.70 |
Previous close | 42.75 |
Average volume | 21.57k |
---|---|
Shares outstanding | 37.58m |
Free float | 8.08m |
P/E (TTM) | 29.83 |
Market cap | 1.61bn USD |
EPS (TTM) | 1.43 USD |
Data delayed at least 15 minutes, as of May 24 2024 19:42 BST.
More ▼